Start studying Farmacos Mucoliticos. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Español; |; 5 Documents; |; Views. Farmacología de los antitusígenos, mucolíticos y expectorantes Share. tos farmacos · estefania · tos farmacos. Laboratorio Elea es una empresa argentina que desde investiga, produce y distribuye medicamentos confiables para diversas especialidades médicas.

Author: Gardakasa Shakarisar
Country: Venezuela
Language: English (Spanish)
Genre: Finance
Published (Last): 5 February 2011
Pages: 189
PDF File Size: 20.45 Mb
ePub File Size: 4.31 Mb
ISBN: 722-3-16243-211-5
Downloads: 4075
Price: Free* [*Free Regsitration Required]
Uploader: Mazuran

Nebulized arformoterol in patients with COPD: Short-acting inhaled betaagonists increased the mortality from chronic obstructive pulmonary disease in observational designs. Em termos absolutos, avaliado em 24 ou 52 semanas, o aumento foi discreto, variando de 24 a 74 mL.

Broncodilatadores, Antitusígenos y Expectorantes. by Anahi Corona on Prezi

Lung function and mortality in the United States: I Professora Titular de Pneumologia. Tiotropium and exercise training in COPD patients: Services on Demand Journal. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization farmaccos pneumonia.

Geographic variations in prevalence and underdiagnosis of COPD: Singh S, Loke YK. Os ICS apresentaram efeitos positivos e negativos, dependendo do desfecho estudado, com alguns efeitos adversos. SCS Quadra 1, Bl.

Medicamentos Mucolíticos

Pneumonia risk in COPD patients receiving inhaled mucolitucos alone or in combination: Comparative safety of long-acting inhaled bronchodilators: Risk of pneumonia associated with long-term use of inhaled corticosteroids in chronic obstructive pulmonary disease: Oral corticosteroid use and the risk of acute myocardial infarction in chronic obstructive pulmonary disease.


A randomized controlled trial to assess the efficacy of tiotropium in Canadian patients with mucolificos obstructive pulmonary disease. Worldwide burden of COPD in high- and low-income countries. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.

There was a problem providing the content you requested

Faster onset of action of formoterol versus salmeterol in patients with chronic obstructive pulmonary disease: Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License.

Ipratropium bromide versus long-acting beta-2 agonists for stable chronic obstructive pulmonary disease. Aclidinium bromide provides long-acting bronchodilation in patients with COPD. Therapeutic conversion of the combination of ipratropium and albuterol to tiotropium in patients with chronic obstructive pulmonary disease. Inhaled corticosteroids for stable chronic obstructive mucolitico disease. Cardiovascular morbidity and the use of inhaled bronchodilators. Safety and efficacy of combined long-acting beta-agonists and inhaled corticosteroids vs long-acting beta-agonists monotherapy for stable COPD: Effect of 1-year treatment with roflumilast in severe chronic obstructive pulmonary disease.

Rubin, Antonio George de M.

Inhaled corticosteroids and the risk of fracture in chronic obstructive pulmonary disease. Inhaled corticosteroids in chronic obstructive pulmonary disease: Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.


Inhaled corticosteroids vs placebo for preventing COPD exacerbations: How to cite this article. Withdrawal of inhaled corticosteroids in people with COPD in primary care: Roflumilast in symptomatic chronic obstructive pulmonary disease: Prevalence and progression of osteoporosis in patients with COPD: Efficacy and safety mucolificos nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Decramer M, Cooper CB.

The effects of long-acting bronchodilators on total mortality in patients with stable chronic obstructive pulmonary disease. Resultados similares foram descritos por Welte et al. Fracture risk in patients with chronic lung diseases treated with muckliticos drugs and inhaled and oral corticosteroids. Short-term effects of montelukast in stable patients with moderate to severe COPD. Comparison of levalbuterol and racemic albuterol in hospitalized patients with acute asthma or COPD: Efficacy of tiotropium inhalation powder in african-american patients with chronic obstructive pulmonary disease.

Improved daytime spirometric efficacy of tiotropium compared with salmeterol in patients with COPD. Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD. Por sua vez, Macie et al.